2-Mercaptobenzothiazole

2-Mercaptobenzothiazole

SCHEMBL5934103

S=c1[nH]c2ccccc2s1.[KH]

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PSMB8 P28062 11/20 0.95
▸ ALDH1A1 P00352 7/20 0.95
▸ KDM4E B2RXH2 4/20 0.95
▸ HPGD P15428 2/20 0.95
▸ CYP3A4 P08684 2/20 0.95
▸ TDP1 Q9NUW8 2/20 0.95
▸ ALOX15 P16050 1/20 0.95
▸ CYP1A2 P05177 2/20 0.57
▸ CYP2C19 P33261 2/20 0.57
▸ GAA P10253 2/20 0.57
▸ CYP2C9 P11712 1/20 0.57
▸ KMT2A Q03164 6/20 0.53
▸ MAPT P10636 5/20 0.53
▸ MEN1 O00255 4/20 0.53
▸ GFER P55789 1/20 0.53
▸ NPSR1 Q6W5P4 1/20 0.53
▸ CRHBP P24387 1/20 0.46
▸ CRHR2 Q13324 1/20 0.46
▸ RAB9A P51151 3/20 0.45
▸ NPC1 O15118 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Mercaptobenzothiazole SCHEMBL29433968 0.98 PSMB8 (1.00) PSMB8ALDH1A1KDM4EHPGDCYP3A4
2-Mercaptobenzothiazole SCHEMBL408087 0.98 PSMB8 (1.00) PSMB8ALDH1A1KDM4EHPGDCYP3A4
2-Mercaptobenzothiazole SCHEMBL8749352 0.95 PSMB8 (0.95) PSMB8ALDH1A1KDM4EHPGDCYP3A4
2-Mercaptobenzothiazole SCHEMBL4268289 0.95 PSMB8 (0.95) PSMB8ALDH1A1KDM4EHPGDCYP3A4
2-Mercaptobenzothiazole SCHEMBL29729650 0.95 PSMB8 (0.95) PSMB8ALDH1A1KDM4EHPGDCYP3A4
2-Mercaptobenzothiazole SCHEMBL19514730 0.86 PSMB8 (0.78) PSMB8ALDH1A1KDM4EHPGDCYP3A4
2-Mercaptobenzothiazole SCHEMBL5933560 0.83 PSMB8 (0.72) PSMB8ALDH1A1KDM4EHPGDCYP3A4
2-Mercaptobenzothiazole SCHEMBL10897718 0.79 PSMB8 (0.66) PSMB8ALDH1A1KDM4EHPGDCYP3A4
SCHEMBL10520003 0.77 PSMB8 (0.63) PSMB8ALDH1A1KDM4EHPGDCYP3A4
SCHEMBL18791144 0.72 PSMB8 (0.61) PSMB8ALDH1A1KDM4EHPGDCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060276339-A1 Methods and compositions for increasing the efficacy of biologically-active ingredients BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2006-12-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276339-A1 Methods and compositions for increasing the efficacy of biologically-active ingredients ENPP1, ENPP3, SMPD1 PSMB8 3746/4885ALDH1A1 2504/4885KDM4E 1139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback